Your session is about to expire
← Back to Search
Behavioral Intervention
Music Therapy for Parkinson's Disease and Lewy Body Dementia
N/A
Waitlist Available
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Admitted as inpatient to UMass Memorial Medical Center University Campus
Diagnosis of PD or DLB (ICD-10 G20 and G31.83 respectively) on active problem list or past medical history OR carbidopa/levodopa on active medication list or ordered in admission orders.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment up to 30 days after enrollment.
Awards & highlights
Study Summary
This trial is testing whether music therapy can prevent hospital-acquired delirium in patients with Parkinson's and Dementia with Lewy Bodies during hospitalization.
Who is the study for?
This trial is for inpatients at UMass Memorial Medical Center with Parkinson's Disease or Dementia with Lewy Bodies. Candidates must be able to hear and enjoy music, not have a history of music-induced seizures, and should not be sedated in intensive care or expected to leave the hospital within 24 hours.Check my eligibility
What is being tested?
The study tests if music therapy can prevent confusion and memory problems (delirium) in patients hospitalized with Parkinson's or Lewy Body Dementia. Participants will receive either guided music therapy, listen to their own choice of music, or get standard care without added music intervention.See study design
What are the potential side effects?
Music therapy is generally safe but may include discomfort from headphones/earbuds use during listening sessions. There are no significant side effects expected from this non-invasive intervention.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently an inpatient at UMass Memorial Medical Center University Campus.
Select...
I have been diagnosed with Parkinson's Disease or Dementia with Lewy Bodies, or I am taking carbidopa/levodopa.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from enrollment up to 30 days after enrollment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment up to 30 days after enrollment.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Confusion Assessment Measure (CAM)
Secondary outcome measures
Medication Administration Records and Orders
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Music TherapyExperimental Treatment1 Intervention
Music therapy intervention will be administered for 30 minutes 3 times per week between Day 0 and Day 15 of inpatient hospitalization. Daily passive music listening will be required for 30 minutes twice a day, at least 4 days per week. This daily listening experience will consist of personalized playlists developed by the music therapist with specific purpose and goal.
Group II: Active ControlActive Control1 Intervention
Daily passive music listening will be required for 30 minutes twice a day, at least 4 days per week. This daily listening experience will consist of non-personalized, auto-generated playlists based on popular genres. No interaction with a music therapist will occur.
Group III: Standard of carePlacebo Group1 Intervention
Usual standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Music therapy intervention
2023
N/A
~110
Find a Location
Who is running the clinical trial?
University of Massachusetts, WorcesterLead Sponsor
344 Previous Clinical Trials
986,852 Total Patients Enrolled
2 Trials studying Delirium
210 Patients Enrolled for Delirium
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there any availability for individuals to join this experiment?
"According to the latest clinicaltrials.gov data, this particular medical study is not currently seeking new participants. Initiated on October 1st 2023 and last updated September 26th 2023, it is one of 1039 active trials that are actively recruiting patients."
Answered by AI
Share this study with friends
Copy Link
Messenger